Robyn Inc. – Trademark Portfolio
Entity Type: 03
Robyn Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ROBYN and PARENTBIRTH. The owner is based in Los Angeles, CA.
145 S. Fairfax Ave, Suites 200 and 300
Los Angeles, CA 90036
Showing of trademarks Trademarks
Trademark Classifications
Robyn Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Robyn Inc. have?
Robyn Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Robyn Inc. file in?
Robyn Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Robyn Inc.'s most well-known trademarks?
Robyn Inc.'s registered trademark portfolio includes well-known marks such as ROBYN and PARENTBIRTH. These are among 2 currently registered trademarks in the portfolio.
What is Robyn Inc.'s trademark registration success rate?
Robyn Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.